CD3 binding antibodies

PH12022550381B1Active Publication Date: 2026-09-30TENEOONE INC

0 Cites 0 Cited by

Patent Information

Application Number: PH12022550381
Authority / Receiving Office: PH · PH
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2022-02-16
Publication Date: 2026-09-30
Estimated Expiration: 2042-02-16

Application Information

Patent Timeline

16 Feb 2022

Application

PH12022550381

30 Sep 2026

Publication

PH12022550381B1

Inventors: TRINKLEIN, Nathan; VAN SCHOOTEN, Wim

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to novel human CD3 antigen-binding polypeptides and their preparation and use in the treatment and / or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and / or treatment of various diseases.

Need to check novelty before this filing date? Find Prior Art